Comorbidity does not appear to have an independent prognostic effect or influence treatment choice in elderly patients with non-localised NSCLC.
We read with interest the report by Janssen-Heijnen and associates on the effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer (NSCLC). 1 The authors concluded that the number of comorbid conditions had no significant influence on the treatment chosen for patients with non-localised disease. We share the authors' opinion that ''comorbidity had no independent prognostic effect''.
No takes yet. Share an insight, caveat, or question.
Goda Choi (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: